Announcements Trials

Browse Landscape

Phase

Phase 2 4 Phase 3 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uveal Melanoma 1 Nevus, Blue 1 Melanoma 1

Interventions

Melphalan 3 tebentafusp 1 sargramostim 1 fotemustine 1 aflibercept 1 Ranibizumab 1 Nivolumab 1 Neoadjuvant Therapy 1 Melatonin 1 MART-1 Antigen 1 Ipilimumab 1 Eye Enucleation 1 Dacarbazine 1 Colony-Stimulating Factors 1 Chemotherapy, Cancer, Regional Perfusion 1 Brachytherapy 1 AZD 6244 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Uveal Melanoma × tebentafusp × Clear all

NCT06246149 2026-03-04

ATOM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡